UNSPSC 51172016: Hymecromone

This classification denotes an indicator, reagent, and coumarin with the molecular formula C10H8O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3T5NG4Q468, chemically known as 2h-1-benzopyren-2-one, 7-hydroxy-4-methyl- but generally known as hymecromone, which bears US NIH Compound Identifier 5280567. European Medicines Agency schedules Hymecromone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08089MIG.

World Health Organization schedules hymecromone in its Anatomical Therapeutic Chemical (ATC) Classification. HYMECROMONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, HYMECROMONE remains the US FDA Preferred Term for this commodity. SMILES: CC1=CC(=O)OC2=C1C=CC(=C2)O.

UNSPSC 51172016 Hymecromone is a Commodity code reflecting pharmaceutical products procured by state and local health and criminal justice agencies for clinical testing, specimen screening, and pharmacy benefit programs. The recent solicitations show that state and local buyers under this code are purchasing drug-testing services bundled with specimen collection and laboratory analysis, as well as generic pharmaceuticals and over-the-counter products distributed through established wholesale channels to public health facilities and employee benefit programs. The issuing bodies include county departments of criminal supervision and corrections, state health and human services commissions, and multi-state cooperative purchasing consortiums; these agencies typically award to single or multiple vendors based on compliance, qualifications, and price competitiveness, with contract terms ranging from two to five years and optional renewal periods subject to annual appropriations.

Activity concentrates in Texas and Minnesota, with recent opportunities spanning different procurement structures and scales. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, covering staffing for two collection sites, immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and electronic result reporting—with an estimated contract value of $600,000 over two years plus three optional one-year renewals and award anticipated August 10, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in March 2026 to gather market intelligence on direct-to-manufacturer prescription programs serving self-insured state agencies and employee health plans, signaling early-stage procurement planning without award amounts or formal evaluation criteria. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (Cencora, Cardinal Health, Morris & Dickson) to participating state and local facilities, with contract terms through June 30, 2028 and vendor performance penalties ranging from $200 to $1,500 per violation.